Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Long-Term ECG Monitoring Helps Diagnose Atrial Fibrillation

By HospiMedica International staff writers
Posted on 12 Apr 2012
A wireless ambulatory monitoring system offers electrophysiologists and cardiologists the advantages of both a Holter electrocardiogram (ECG) and cardiac event monitor in one device.

The TruVue ECG Monitoring System is intended for the diagnosis and management of atrial fibrillation (AF) and other complex cardiac arrhythmia, as well as serving as a platform for pharmaceutical and medical device companies to assess the cardiovascular safety and efficacy associated with new drugs and devices. More...
The system’s diagnostic benefits include the ability to record and wirelessly transmit every heartbeat for up to 30 days; perform advanced arrhythmia analysis; and to provide immediate online access to all transmitted ECG data.

The patented technology employs cellular communication to transmit recordings of every heartbeat to secure servers, where proprietary algorithms analyze the incoming data for changes in morphology, rate, or rhythm. Patients can also initiate alerts when symptoms are experienced. Certified cardiac technicians validate the findings, post reports in real time, and alert physicians based on cardiac events or notification criteria. At any time, physicians can access information online, including any portion of the recorded ECG monitoring and trend reports detailing 24-hour heart rate and rhythm abnormalities, including AF. The TruVue ECG Monitoring System is a product of Biomedical Systems (St. Louis, MO, USA).

“TruVue expedites the diagnoses of patients who may have cardiac arrhythmia, including atrial fibrillation, by delivering the most comprehensive long-term view of the heart rhythm,” said Jim Ott, president of the cardiology division at Biomedical Systems. “With TruVue, we provide physicians with the unique ability to review every heartbeat for up to 30 days, combining both algorithm-triggered ECG-recordings and episodes recorded by patients, and immediately access information online without working through support staff.”

A Holter monitor (named for physicist Dr. Norman J. Holter, who invented telemetric cardiac monitoring in 1949) is a portable device for continuously monitoring various electrical activity of the cardiovascular system or monitoring brain activity for at least 24 hours (often for two weeks at a time). The extended recording period is useful for observing occasional cardiac arrhythmias or epileptic events, which would be difficult to identify in a shorter period of time. For patients having more transient symptoms, a cardiac event monitor, which can be worn for a month or more, can be used.

Related Links:
Biomedical Systems


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
OR Table Accessory
Angular Accessory Rail
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.